If you're looking for a textbook example of a steady rise in shares, it doesn't get much better than the current Johnson & Johnson stock run-up. Shares in the blue-chip company are up 15% year-to-date with a nice upward trend. JNJ data …
After a strong surge in fiscal 2016, Johnson & Johnson’s (NYSE:JNJ) stock price extended the rally into this year, buoyed by an overall advance at the stock market and the company’s growth strategy. JNJ shares soared 9.55% since …
Greenwood Capital Associates Llc acquired 4,695 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The …
Johnson & Johnson (NYSE:JNJ) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Monday, May 15th. The firm presently has a …
BNS1mon
Johnson & Johnson (NYSE: JNJ) stock first traded back in 1944. For the first 58 years of the company's existence, it was privately held by the Johnson family. J&J stock has been a big winner throughout the years, but never more so …
Legendary UCLA basketball coach John Wooden was famous for saying “preparation is the prize.” He explained what he meant by this concept on page 53 of his biography “Wooden: A Lifetime of Observations and Reflections On and Off …
Usually, I like to look for strong stocks getting stronger. However, when some large caps give you a big pullback, it can be a timely place to look at the stock. Today, JNJ looks interesting. I plotted two lines on the SCTR. One at 25 and one at …
Private Na reported 1.53% of its portfolio in Johnson & Johnson (NYSE:JNJ). About 1,600 shares traded. It has underperformed by 3.61% the S&P500. Chao Ku increased its stake in Johnson & Johnson (JNJ) by 394.74% based …
JNJ Stock a Top Dividend Name for 2016 and Beyond Johnson 38; Johnson (NYSE:JNJ) is an old stalwart, known for being one of the most reliable stocks for dividend investors. It is among an elite class of companies that have increased …
The company was maintained on Wednesday, October 14 by S&P Research. Vident Investment Advisory Llc decreased Johnson & Johnson (JNJ) stake by 54.78% reported in 2016Q4 SEC filing. The firm has "Buy" rating given on …